Protocol · Neurological Health
Parkinson's Disease Protocol
Mucuna Pruriens and Coenzyme Q10 are the core of this stack, with 5 supporting supplements. Each row gives the amount the protocol lists and the grade our evidence database holds for that supplement in Parkinson's Disease.
We are re-verifying the studies cited on protocol pages; only confirmed citations are shown.
The stack
7 supplements · 3 graded · 1 graded A · 3 confirmed studies
| Grade | Supplement | Amount listed | Why it’s in the stack | Evidence on file |
|---|---|---|---|---|
| Primary stackThe core of this protocol | ||||
| Mucuna Pruriens | Amount listed: 15–30 g seed powder (standardized for L-DOPA content) under medical supervision | Natural source of L-DOPA, the precursor to dopamine; may provide symptomatic benefit similar to pharmaceutical levodopa
| Grade A for Parkinson's Disease Symptoms3 studies · 40 people | |
Confirmed studies for Mucuna Pruriens (titles as PubMed lists them) | ||||
| Coenzyme Q10 | Amount listed: 300–1,200 mg daily (higher doses studied for neuroprotection) | Supports mitochondrial function and may slow disease progression; addresses mitochondrial dysfunction in Parkinson's
| Not graded yet | |
Confirmed studies for Coenzyme Q10 (titles as PubMed lists them) | ||||
| Supporting stackListed as additions to the core | ||||
| Vitamin D | Amount listed: 2,000–4,000 IU daily (based on blood levels) | Deficiency highly prevalent in PD; supplementation may support motor function and reduce falls
| Grade B for 6-Minute Walking Test Performance191 people | |
| Creatine | Amount listed: 5–10 g daily | Supports brain energy metabolism and may have neuroprotective effects; helps maintain muscle mass
| Grade D for Parkinson's Disease Symptoms4 studies · 194 people | |
Confirmed studies for Creatine (titles as PubMed lists them) | ||||
| Omega-3 Fatty Acids | Amount listed: 2–4 g EPA/DHA daily | Anti-inflammatory and neuroprotective; supports brain cell membrane health | Not graded yet | |
| Curcumin | Amount listed: 500–1,000 mg daily (enhanced absorption formula) | Crosses blood-brain barrier; anti-inflammatory and may inhibit alpha-synuclein aggregation | Not graded yet | |
| N-Acetylcysteine (NAC) | Amount listed: 600–1,800 mg daily | Replenishes glutathione, which is depleted in Parkinson's; antioxidant support for dopaminergic neurons | Not graded yet | |
How this protocol works
In plain language
Parkinson's disease is a progressive neurological condition caused by the death of dopamine-producing neurons in a brain area called the substantia nigra. This leads to motor symptoms (tremor, rigidity, slowness of movement, balance problems) and non-motor symptoms (depression, sleep problems, cognitive changes, constipation). The disease involves mitochondrial dysfunction, oxidative stress, and accumulation of a protein called alpha-synuclein. While medications like levodopa/carbidopa are the mainstay of treatment, certain supplements may provide additional support.
IMPORTANT: These supplements are meant to complement, not replace, your neurologist's treatment plan. Mucuna pruriens in particular contains L-DOPA and can interact with Parkinson's medications—use only under medical supervision.
- Mucuna Pruriens (velvet bean) is a natural source of L-DOPA, the same compound that's converted to dopamine in the brain and is the basis for levodopa medication. Studies show Mucuna may provide comparable symptom relief to synthetic levodopa, with potentially fewer side effects like dyskinesia. However, the L-DOPA content varies between products, making dosing challenging. It must be used under neurologist supervision, especially if already taking levodopa medications.
- Coenzyme Q10 supports the mitochondria, which are impaired in Parkinson's. Early studies showed that high doses (1200mg/day) might slow disease progression, though a large later trial was stopped for futility. CoQ10 is still considered reasonable for its antioxidant properties and cardiac benefits (important since many PD meds affect the heart).
- Vitamin D deficiency is extremely common in Parkinson's patients and is associated with worse motor symptoms and increased falls. Supplementation may improve motor function and reduce fracture risk from falls—a major concern in PD.
- Creatine supports brain energy metabolism and has shown neuroprotective effects in laboratory studies. While large clinical trials haven't shown major benefit for slowing progression, it helps maintain muscle mass and strength, which is important for mobility.
- Omega-3 Fatty Acids have anti-inflammatory and neuroprotective properties. They support brain cell membrane health and may help with depression, which is common in Parkinson's.
- Curcumin can cross the blood-brain barrier and has been shown in laboratory studies to inhibit the aggregation of alpha-synuclein (the protein that clumps in Parkinson's). It also has powerful anti-inflammatory effects. Clinical evidence is still preliminary.
- N-Acetylcysteine (NAC) replenishes glutathione, the brain's major antioxidant, which is significantly depleted in Parkinson's patients. Early studies show it may reach the brain and increase dopamine transporter availability.
Expected timeline: Mucuna: effects similar to levodopa timing (within days-weeks). CoQ10/creatine: ongoing neuroprotective support. Vitamin D: 2-3 months. Curcumin/NAC: 4-8 weeks for potential benefits.